Shanghai Junshi Biosciences Co., Ltd. (1877.HK)
HKD 16.26
(-0.49%)
HKD 16.26
(-0.49%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 11.36 Billion CNY | -9.65% |
| 2022 | 12.57 Billion CNY | 13.81% |
| 2021 | 11.05 Billion CNY | 37.95% |
| 2020 | 8.01 Billion CNY | 81.14% |
| 2019 | 4.42 Billion CNY | 3.88% |
| 2018 | 4.25 Billion CNY | 249.04% |
| 2017 | 1.21 Billion CNY | 6.15% |
| 2016 | 1.14 Billion CNY | 82.86% |
| 2015 | 628.38 Million CNY | 88.74% |
| 2014 | 332.93 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 12.02 Billion CNY | 5.83% |
| 2024 Q2 | 11 Billion CNY | -8.45% |
| 2023 Q3 | 11.58 Billion CNY | -1.79% |
| 2023 Q4 | 11.36 Billion CNY | -1.94% |
| 2023 FY | 11.36 Billion CNY | -9.65% |
| 2023 Q1 | 12.13 Billion CNY | -3.54% |
| 2023 Q2 | 11.79 Billion CNY | -2.74% |
| 2022 FY | 12.57 Billion CNY | 13.81% |
| 2022 Q4 | 12.57 Billion CNY | 31.26% |
| 2022 Q3 | 9.58 Billion CNY | -3.25% |
| 2022 Q2 | 9.9 Billion CNY | -9.59% |
| 2022 Q1 | 10.95 Billion CNY | -0.88% |
| 2021 Q3 | 9.59 Billion CNY | -4.49% |
| 2021 Q4 | 11.05 Billion CNY | 15.21% |
| 2021 Q1 | 8.55 Billion CNY | 6.76% |
| 2021 FY | 11.05 Billion CNY | 37.95% |
| 2021 Q2 | 10.04 Billion CNY | 17.42% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 FY | 8.01 Billion CNY | 81.14% |
| 2020 Q2 | 4.56 Billion CNY | 0.0% |
| 2020 Q3 | 8.13 Billion CNY | 78.13% |
| 2020 Q4 | 8.01 Billion CNY | -1.51% |
| 2019 Q1 | 4.45 Billion CNY | 4.67% |
| 2019 FY | 4.42 Billion CNY | 3.88% |
| 2019 Q4 | 4.42 Billion CNY | 0.0% |
| 2019 Q2 | 4.64 Billion CNY | 4.15% |
| 2018 Q3 | 1.48 Billion CNY | -3.53% |
| 2018 FY | 4.25 Billion CNY | 249.04% |
| 2018 Q4 | 4.25 Billion CNY | 186.93% |
| 2018 Q2 | 1.53 Billion CNY | 0.0% |
| 2018 Q1 | - CNY | -100.0% |
| 2017 FY | 1.21 Billion CNY | 6.15% |
| 2017 Q1 | 1.32 Billion CNY | 15.56% |
| 2017 Q2 | 1.32 Billion CNY | 0.0% |
| 2017 Q4 | 1.21 Billion CNY | 0.0% |
| 2016 FY | 1.14 Billion CNY | 82.86% |
| 2016 Q1 | 860.32 Million CNY | 36.91% |
| 2016 Q2 | 860.32 Million CNY | 0.0% |
| 2016 Q3 | 1.14 Billion CNY | 33.56% |
| 2016 Q4 | 1.14 Billion CNY | 0.0% |
| 2015 Q2 | 137.03 Million CNY | 0.0% |
| 2015 Q1 | 137.03 Million CNY | -58.84% |
| 2015 Q4 | 628.38 Million CNY | 0.0% |
| 2015 Q3 | 628.38 Million CNY | 358.54% |
| 2015 FY | 628.38 Million CNY | 88.74% |
| 2014 FY | 332.93 Million CNY | 0.0% |
| 2014 Q4 | 332.93 Million CNY | 0.0% |
| 2014 Q3 | 332.93 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 409.99 Million HKD | -2671.387% |
| CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | -1.023% |